Arrivo Bio will be giving both an oral and poster presentation at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 26–29 in Miami, Florida. The ...
Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced the presentation of new preclinical data for ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with advanced AI ...
Highlighting new biomarker data and research supporting precision development of the “‘stinel” class at the 2023 ASCP Annual Meeting Gate’s Head of Research, Dr. Jeffrey Burgdorf, Ph.D., presenting ...
Diana Lin, M.D., an associate professor in the UAB Department of Pathology's Division of Anatomic Pathology, is among 40 high-achieving pathologists, pathology residents and medical laboratory ...
Oral and poster presentations highlight first-in-human SIRT6 activator and prior Phase 2 signal in females with major depressive disorder MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo Bio will be giving ...
Autobahn Therapeutics Presents New Preclinical Data at ASCP Annual Meeting Demonstrating Elunetirom Drives Robust Bioenergetic and Neuroplastic Improvements in Neuronal Cultures New preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results